With your help, target pediatric aml can...
Jumpstart personalized, precision medicine for young AML patients
Create a fundamental shift in how AML is diagnosed, monitored and treated
comprehensively identify the vulnerabilities
of pediatric AML through collaboration
TOGETHER, We can overcome pediatric aml.
Accelerating the “highest potential, greatest-need”, strategic research project can fundamentally change how AML is treated in young patients ages 0-35.
Did you know?
The vast majority of all AML funding goes to The adult form
Pediatric AML is categorically different
A majority of treatments were tested and designed for adult patients with AML, and are passed down to kids.
Kids and teens fighting AML often find themselves at the “end of the line” waiting for new, “hand-me-down” therapies designed for older adults.
Targeted, personalized treatments are incredibly promising, yet lack necessary funding.